Endocrine Abstracts

Background: COVID-19 pandemic is a novel, potentially adverse condition for patients with adrenal insufficiency (AI), whose life expectancy and quality of life (QoL) are impaired due to their risk of infections and stress-triggered acute events. Therapeutic usefulness of glucocorticoids in COVID-19 is debated, but infected AI patients require prompt replacement tailoring.Objectives: In a cohort of AI patients, to assess:– the...

Insulinoma is a rare neuroendocrine tumor (4 cases/1000000/year), less than 10% are malignant. We report a case of rapidly fatal malignant insulinoma, death occurring less than 3 months after the apparition of hypoglycaemic symptoms.A 79 years old female type 2 diabetic patient, treated with glicazide120 mg b.i.d and metformine et 850 t.i.d, was hospitalized for recurrent hypoglycaemia Insulinoma was diagnosed as severe hypoglycaemic episodes occurred mo...

Background: Dysnatremia is common in hospitalized patients, often worsening the prognosis in pneumopathies and critical illnesses, such as COVID-19. Here, hyponatremia is an indicator of pulmonary involvement, while hypernatremia is associated with worse assistance outcomes, particularly when resulting from an overcorrected hyponatremia. Longer hospitalizations, readmissions after discharge and higher short- and long-term mortality rates have been observed in acute patients ex...